Use of Lung Clearance Index (LCI) to distinguish asthmatics within a symptomatic population.
L. Healy (Manchester, United Kingdom), C. Murray (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), S. Drake (Manchester, United Kingdom), R. Wang (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), J. Sale (Manchester, United Kingdom), R. Tudge (Manchester, United Kingdom), G. Kerry (Manchester, United Kingdom), L. Lowe (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom)
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Healy (Manchester, United Kingdom), C. Murray (Manchester, United Kingdom), A. Simpson (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), S. Drake (Manchester, United Kingdom), R. Wang (Manchester, United Kingdom), L. Willmore (Manchester, United Kingdom), J. Sale (Manchester, United Kingdom), R. Tudge (Manchester, United Kingdom), G. Kerry (Manchester, United Kingdom), L. Lowe (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom). Use of Lung Clearance Index (LCI) to distinguish asthmatics within a symptomatic population.. 1852
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: